This content is machine translated Precision therapy Targeted MET inhibition after progression with osimertinib Despite the success of osimertinib, a third-generation EGFR-TKI, in first-line therapy, the treatment of NSCLC after progression remains a challenge. SAVANNAH and ORCHARD have investigated the targeted addition of additional...…
View Post 0 min This content is machine translated Advanced NSCLC MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC ... Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post 14 min This content is machine translated Lung cancer Multidisciplinary teams in oncology The treatment of cancer is one of the greatest challenges of modern medicine. The complexity of oncological diagnostics and therapy, the multitude of treatment options available and the need to...… CME-Test
View Post 3 min This content is machine translated Non-small cell lung cancer Management of locally advanced NSCLC – where are we heading? Lung cancer is the second most common and deadliest type of cancer worldwide. Clinically, non-small cell lung cancer (NSCLC) is the most common pathologic form of lung cancer; approximately one-third…
View Post 5 min This content is machine translated Lung cancer Perioperative therapy for better efficacy Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients with resectable non-small cell lung cancer (NSCLC). It has now been observed that perioperative therapies can combine the benefits of both…
View Post 8 min This content is machine translated Lung cancer An overview of non-small cell lung cancer across all stages The European Lung Cancer Congress is a joint project of major multidisciplinary societies representing thoracic oncology specialists working together to advance science, disseminate education and improve the practice of lung…
View Post 3 min This content is machine translated Pneumooncology Optimal treatment of non-small cell lung cancer The treatment management of non-small cell lung cancer has improved significantly in recent years. Innovative treatment options point the way to personalized therapy with fewer side effects and an improved…
View Post 6 min This content is machine translated Non-small cell lung cancer Risk-adapted screening and treatment management Non-small cell lung carcinomas are the most common malignant tumors of the lung. 70–80% of all lung tumors can be assigned to this histology. A distinction can now be made…
View Post 7 min This content is machine translated Lung cancer Current research results for optimized management The European Lung Cancer Congress brings together key multidisciplinary societies to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. At this year’s event, attendees were…
View Post 10 min This content is machine translated Chemo in hospice? Systems therapies for metastatic NSCLC in poor general health Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with… CME-Test
View Post 10 min This content is machine translated Chemo in hospice? Systems therapies for metastatic NSCLC in poor general health. Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with… CME-Test
